Literature DB >> 35235176

Two years of COVID-19 pandemic: where are we now?

Jinjong Myoung1.   

Abstract

Unprecedented. This is the closest and most appropriate word to describe the COVID-19 pandemic, which the world has been experiencing with pain and fear. The first case of pneumonia-like symptoms of unknown etiology appeared presumably in November 2019, with the subsequent official report to the WHO by the Chinese authorities on December 31, 2019. China's first confirmed death from the virus occurred on January 11, 2020, when a 61-year-old male resident of Hubei, the capital of Wuhan Province, died. Within a month, the COVID-19 death toll surpassed 1,000 (February 10, 2020). Accordingly, just 30 days after the initial report, the coronavirus outbreak was called a "public health emergency of international concern" by the WHO, the organization's highest alert level. Unfortunately, the WHO soon declared the COVID-19 outbreak a pandemic (March 11, 2020). Within a year of viral emergence, and by December 2020, more than 80 million confirmed cases had been reported worldwide. Infections increased exponentially over the following year. As of February 11, 2022, over 400 million cases have been reported, with nearly 6 million deaths, an unprecedented rate of spread across borders.
© 2022. The Microbiological Society of Korea.

Entities:  

Mesh:

Year:  2022        PMID: 35235176      PMCID: PMC8890008          DOI: 10.1007/s12275-022-1679-x

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  12 in total

Review 1.  Protective and pathogenic role of humoral responses in COVID-19.

Authors:  Uni Park; Nam-Hyuk Cho
Journal:  J Microbiol       Date:  2022-03-02       Impact factor: 2.902

Review 2.  A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization.

Authors:  Sameer-Ul-Salam Mattoo; Jinjong Myoung
Journal:  J Microbiol Biotechnol       Date:  2021-12-28       Impact factor: 2.351

Review 3.  Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins.

Authors:  Na-Eun Kim; Yoon-Jae Song
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

Review 4.  Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2.

Authors:  Chulwoo Kim; Jae-Deog Kim; Sang-Uk Seo
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

Review 5.  Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies.

Authors:  Jung-Ah Choi; Jae-Ouk Kim
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

Review 6.  Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants.

Authors:  Junsoo Park; Rackhyun Park; Minsu Jang; Yea-In Park; Yeonjeong Park
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

Review 7.  Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines.

Authors:  Heedo Park; Mee Sook Park; Jong Hyeon Seok; Jaehwan You; Jineui Kim; Jeonghun Kim; Man-Seong Park
Journal:  J Microbiol       Date:  2022-03-02       Impact factor: 2.902

Review 8.  COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity.

Authors:  Mi-Hyun Lee; Bum-Joon Kim
Journal:  J Microbiol       Date:  2022-02-14       Impact factor: 2.902

Review 9.  SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.

Authors:  Soo-Jin Oh; Ok Sarah Shin
Journal:  J Microbiol       Date:  2022-02-05       Impact factor: 2.902

Review 10.  T cell responses to SARS-CoV-2 in humans and animals.

Authors:  Sameer-Ul-Salam Mattoo; Jinjong Myoung
Journal:  J Microbiol       Date:  2022-02-14       Impact factor: 2.902

View more
  1 in total

1.  Challenges of rapamycin repurposing as a potential therapeutic candidate for COVID-19: implications for skeletal muscle metabolic health in older persons.

Authors:  Matthew J Lees; Nathan Hodson; Cassidy T Tinline-Goodfellow; Hugo J W Fung; Antonis Elia; Daniel R Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-05-06       Impact factor: 5.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.